Phamaniaga submits regularisation plan to Bursa

PETALING JAYA: Pharmaniaga Bhd has submitted its regularisation plan to Bursa Malaysia, marking a critical milestone in its efforts to recover, enhance its financial standing and exit Practice Note 17 (PN17) status.

The pharmaceutical group, in a statement, said the regularisation plan outlines a holistic approach to increase the equity of the group and minimise the group’s accumulated losses.